| Nanomedicine applications in the treatment of breast cancer: current state of the art D Wu, M Si, HY Xue, HL Wong International journal of nanomedicine, 5879-5892, 2017 | 191 | 2017 |
| Applications, challenges, and outlook for PBPK modeling and simulation: a regulatory, industrial and academic perspective W Lin, Y Chen, JD Unadkat, X Zhang, D Wu, T Heimbach Pharmaceutical Research 39 (8), 1701-1731, 2022 | 94 | 2022 |
| Physiologically based pharmacokinetics modeling in biopharmaceutics: case studies for establishing the bioequivalence safe space for innovator and generic drugs D Wu, M Sanghavi, S Kollipara, T Ahmed, AK Saini, T Heimbach Pharmaceutical Research 40 (2), 337-357, 2023 | 45 | 2023 |
| Current state and challenges of physiologically based biopharmaceutics modeling (PBBM) in oral drug product development D Wu, M Li Pharmaceutical Research 40 (2), 321-336, 2023 | 29 | 2023 |
| Incorporation of docosahexaenoic acid (DHA) enhances nanodelivery of antiretroviral across the blood-brain barrier for treatment of HIV reservoir in brain P Guo, M Si, D Wu, HY Xue, W Hu, HL Wong Journal of Controlled Release 328, 696-709, 2020 | 18 | 2020 |
| Understanding In Vivo Dissolution of Immediate Release (IR) Solid Oral Drug Products Containing Weak Acid BCS Class 2 (BCS Class 2a) Drugs M Li, X Zhang, D Wu, O Anand, H Chen, K Raines, L Yu The AAPS Journal 23, 1-13, 2021 | 14 | 2021 |
| Physiologically based pharmacokinetic models under the prism of the finite absorption time concept D Wu, AA Tsekouras, P Macheras, F Kesisoglou Pharmaceutical Research 40 (2), 419-429, 2023 | 11 | 2023 |
| Assessing and mitigating pH-mediated DDI risks in drug development–formulation approaches and clinical considerations D Wu, J Liu, EM Paragas, J Yadav, T Aliwarga, T Heimbach, ... Drug Metabolism Reviews, 1-20, 2024 | 3 | 2024 |
| Physiologically Based Biopharmaceutics Modeling for Gefapixant IR Formulation Development and Defining the Bioequivalence Dissolution Safe Space M Wang, T Heimbach, W Zhu, D Wu, KG Reuter, F Kesisoglou The AAPS Journal 26 (4), 69, 2024 | 1 | 2024 |
| Lipid nanocarrier targeting activated macrophages for antiretroviral therapy of HIV reservoir D Wu, M Si, HY Xue, NT Tran, K Khalili, R Kaminski, HL Wong Nanomedicine 18 (20), 1343-1360, 2023 | 1 | 2023 |
| Physiologically Based Pharmacokinetic (PBPK) modeling application on food effect assessment D Wu, JP Gleeson, F Kesisoglou Advances in Pharmacokinetics and Pharmacodynamics, 29-56, 2023 | 1 | 2023 |
